Page last updated: 2024-10-21

cgp 52411 and Alloxan Diabetes

cgp 52411 has been researched along with Alloxan Diabetes in 1 studies

4,5-dianilinophthalimide: structure given in first source
4,5-dianilinophthalimide : Phthalimide substituted at the 4- and 5-positions by anilino groups.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, Y1
Jin, J1
Qiao, S1
Lei, S1
Liao, S1
Ge, ZD1
Li, H1
Wong, GT1
Irwin, MG1
Xia, Z1

Other Studies

1 other study available for cgp 52411 and Alloxan Diabetes

ArticleYear
Inhibition of PKCĪ²2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling.
    Clinical science (London, England : 1979), 2015, Volume: 129, Issue:4

    Topics: Animals; Apoptosis; Caveolin 3; Cell Line; Diabetes Mellitus, Experimental; Dinoprost; Enzyme Activa

2015